Egr-1: New conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)

Journal of Pathology

Volumn 229, Issue 2, 2013, Pages 286-297

  Bhattacharyya, Swati ^a   Fang, Feng ^a   Tourtellotte, Warren ^a   Varga, John ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

c Abl; Egr 1; fibroblast; fibrosis; myofibroblast; Nab2; p300; scleroderma; TGF

Indexed keywords

ABELSON KINASE; BINDING PROTEIN; BLEOMYCIN; CYCLOSPORIN; E1A ASSOCIATED P300 PROTEIN; EARLY GROWTH RESPONSE FACTOR; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 2; EARLY GROWTH RESPONSE FACTOR 3; EARLY GROWTH RESPONSE FACTOR 4; IMATINIB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIOGLITAZONE; ROSIGLITAZONE; SIMVASTATIN; UNCLASSIFIED DRUG;

CHRONIC MYELOID LEUKEMIA; EXPERIMENTAL MODEL; FIBROBLAST; FIBROGENESIS; FIBROSIS; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; GENETIC REGULATION; HUMAN; LUNG INJURY; NEGATIVE FEEDBACK; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGENERATION; REVIEW; SKIN FIBROSIS; TISSUE REPAIR;

ANIMALS; COLLAGEN; DISEASE MODELS, ANIMAL; EARLY GROWTH RESPONSE PROTEIN 1; EARLY GROWTH RESPONSE PROTEIN 2; FEEDBACK, PHYSIOLOGICAL; FIBROBLASTS; FIBROSIS; HUMANS; LUNG INJURY; MYOFIBROBLASTS; P300-CBP TRANSCRIPTION FACTORS; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-ABL; REGENERATION; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84871066557     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4131     Document Type: Review

References (100)

1. Wynn TA,. Fibrosis under arrest. Nat Med 2010; 16: 523-525.
2. Bhattacharyya S, Wei J, Varga J,. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 2012; 8: 42-54.
3. Mehal WZ, Iredale J, Friedman SL,. Scraping fibrosis: expressway to the core of fibrosis. Nat Med 2011; 17: 552-553.
4. Rahimi RA, Leof EB,. TGFβ signaling: a tale of two responses. JCell Biochem 2007; 102: 593-608. (Pubitemid 47557414)
5. Milbrandt J,. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 1987; 238: 797-799. (Pubitemid 18005238)
6. Gashler A, Sukhatme VP,. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 1995; 50: 191-224.
7. Svaren J, Sevetson BR, Apel ED, et al,. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol 1996; 16: 3545-3553. (Pubitemid 26199873)
8. Russo MW, Sevetson BR, Milbrandt J,. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc Natl Acad Sci USA 1995; 92: 6873-6877.
9. Srinivasan R, Mager GM, Ward RM, et al,. NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex. J Biol Chem 2006; 281: 15129-15137. (Pubitemid 43855102)
10. Ehrengruber MU, Muhlebach SG, Sohrman S, et al,. Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus. Gene 2000; 258: 63-69.
11. Hjoberg J, Le L, Imrich A, et al,. Induction of early growth-response factor 1 by platelet-derived growth factor in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2004; 286: L817-825. (Pubitemid 38365068)
12. Yan SF, Fujita T, Lu J, et al,. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000; 6: 1355-1361. (Pubitemid 32001019)
13. Gaggioli C, Deckert M, Robert G, et al,. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1. Oncogene 2005; 24: 1423-1433. (Pubitemid 40343122)
14. Guha M, O'Connell MA, Pawlinski R, et al,. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor-α expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 2001; 98: 1429-1439.
15. Li CJ, Ning W, Matthay MA, et al,. MAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine production. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1297-1303. (Pubitemid 47084876)
16. Kaufmann K, Thiel G,. Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J Cell Biochem 2002; 85: 381-391. (Pubitemid 34274905)
17. 2+ concentration, phosphorylation of ERK and activation of ternary complex factor. BMC Mol Biol 2009; 10: 40.
18. Iyoda T, Zhang F, Sun L, et al,. Lysophosphatidic acid induces early growth response-1 (Egr-1) protein expression via protein kinase Cδ-regulated extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) activation in vascular smooth muscle cells. J Biol Chem 2012; 287: 22635-22642.
19. Buchwalter G, Gross C, Wasylyk B,. Ets ternary complex transcription factors. Gene 2004; 324: 1-14. (Pubitemid 38030321)
20. Hasan RN, Schafer AI,. Hemin upregulates Egr-1 expression in vascular smooth muscle cells via reactive oxygen species ERK-1/2-Elk-1 and NF-κB. Circ Res 2008; 102: 42-50.
21. Midgley VC, Khachigian LM,. Fibroblast growth factor-2 induction of platelet-derived growth factor-C chain transcription in vascular smooth muscle cells is ERK-dependent but not JNK-dependent and mediated by Egr-1. J Biol Chem 2004; 279: 40289-40295. (Pubitemid 39287613)
22. Pagel JI, Deindl E,. Early growth response 1-a transcription factor in the crossfire of signal transduction cascades. Indian J Biochem Biophys 2011; 48: 226-235.
23. Cao X, Mahendran R, Guy GR, et al,. Detection and characterization of cellular EGR-1 binding to its recognition site. J Biol Chem 1993; 268: 16949-16957. (Pubitemid 23236918)
24. Bae MH, Jeong CH, Kim SH, et al,. Regulation of Egr-1 by association with the proteasome component C8. Biochim Biophys Acta 2002; 1592: 163-167.
25. Yu J, de Belle I, Liang H, et al,. Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol Cell 2004; 15: 83-94. (Pubitemid 38850221)
26. Huang RP, Fan Y, deBelle I, et al. Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation. Cell Death Differ 1998; 5: 96-106. (Pubitemid 28359087)
27. Yu J, Zhang SS, Saito K, et al,. PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J 2009; 28: 21-33.
28. Manente AG, Pinton G, Tavian D, et al,. Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability. PLoS One 2011; 6: e25676.
29. Krones-Herzig A, Mittal S, Yule K, et al,. Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Res 2005; 65: 5133-5143. (Pubitemid 40827322)
30. Tureyen K, Brooks N, Bowen K, et al,. Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem 2008; 105: 1313-1324. (Pubitemid 351590795)
31. McCaffrey TA, Fu C, Du B, et al,. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest 2000; 105: 653-662. (Pubitemid 30146512)
32. Khachigian LM,. Early growth response-1 in cardiovascular pathobiology. Circ Res 2006; 98: 186-191.
33. Bhattacharyya S, Chen SJ, Wu M, et al,. Smad-independent transforming growth factor-β regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma. Am J Pathol 2008; 173: 1085-1099.
34. Wu M, Melichian DS, de la Garza M, et al,. Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing. Am J Pathol 2009; 175: 1041-1055.
35. Yu J, Baron V, Mercola D, et al,. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells. Cell Death Differ 2007; 14: 436-446.
36. Baron V, Adamson ED, Calogero A, et al,. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin. Cancer Gene Ther 2006; 13: 115-124. (Pubitemid 43113412)
37. Ritchie MF, Zhou Y, Soboloff J,. WT1/EGR1-mediated control of STIM1 expression and function in cancer cells. Front Biosci 2012; 17: 2402-2415.
38. Lee SL, Sadovsky Y, Swirnoff AH, et al,. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 1996; 273: 1219-1221. (Pubitemid 26293210)
39. Topilko P, Schneider-Maunoury S, Levi G, et al,. Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol 1998; 12: 107-122. (Pubitemid 28124784)
40. Liao Y, Shikapwashya ON, Shteyer E, et al,. Delayed hepatocellular mitotic progression and impaired liver regeneration in early growth response-1-deficient mice. J Biol Chem 2004; 279: 43107-43116. (Pubitemid 39372206)
41. Lee CG, Cho SJ, Kang MJ, et al,. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β1-induced pulmonary fibrosis. J Exp Med 2004; 200: 377-389. (Pubitemid 39031256)
42. Cho SJ, Kang MJ, Homer RJ, et al,. Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling. J Biol Chem 2006; 281: 8161-8168. (Pubitemid 43847435)
43. Saadane N, Alpert L, Chalifour LE,. Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. Am J Physiol Heart Circ Physiol 2000; 278: H796-805. (Pubitemid 30152536)
44. Bhattacharyya S, Wu M, Fang F, et al,. Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy. Matrix Biol 2011; 30: 235-242.
45. Chen SJ, Ning H, Ishida W, et al,. The early-immediate gene EGR-1 is induced by transforming growth factor-β and mediates stimulation of collagen gene expression. J Biol Chem 2006; 281: 21183-21197. (Pubitemid 44115458)
46. Yasuoka H, Hsu E, Ruiz XD, et al,. The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms. Am J Pathol 2009; 175: 605-615.
47. Thiel G, Cibelli G,. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 2002; 193: 287-292. (Pubitemid 35265949)
48. Friedrich B, Janessa A, Artunc F, et al,. DOCA and TGFβ induce early growth response gene-1 (Egr-1) expression. Cell Physiol Biochem 2008; 22: 465-474.
49. Yu HW, Liu QF, Liu GN,. Positive regulation of the Egr-1/osteopontin positive feedback loop in rat vascular smooth muscle cells by TGFβ, ERK, JNK, and p38 MAPK signaling. Biochem Biophys Res Commun 2010; 396: 451-456.
50. Grotegut S, von Schweinitz D, Christofori G, et al,. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 2006; 25: 3534-3545. (Pubitemid 44264864)
51. Wu M, Melichian DS, Chang E, et al,. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-γ. Am J Pathol 2009; 174: 519-533.
52. Yamaguchi Y, Takihara T, Chambers RA, et al,. A Peptide derived from endostatin ameliorates organ fibrosis. Sci Transl Med 2012; 4: 136ra171.
53. Bhattacharyya S, Sargent JL, Du P, et al,. Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis. PLoS One 2011; 6: e23082.
54. Gabrielli A, Avvedimento EV, Krieg T,. Scleroderma. N Engl J Med 2009; 360: 1989-2003.
55. Bhattacharyya S, Ishida W, Wu M, et al,. A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate. Oncogene 2009; 28: 1285-1297.
56. Wilkes MC, Leof EB,. Transforming growth factor-β activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures. J Biol Chem 2006; 281: 27846-27854. (Pubitemid 44414496)
57. Daniels CE, Wilkes MC, Edens M, et al,. Imatinib mesylate inhibits the profibrogenic activity of TGFβ and prevents bleomycin-mediated lung fibrosis. J Clin Invest 2004; 114: 1308-1316. (Pubitemid 40385302)
58. Wang S, Wilkes MC, Leof EB, et al,. Imatinib mesylate blocks a non-Smad TGFβ pathway and reduces renal fibrogenesis in vivo. FASEB J 2005; 19: 1-11. (Pubitemid 40069914)
59. Distler JH, Jungel A, Huber LC, et al,. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum 2007; 56: 311-322. (Pubitemid 46106205)
60. Ghosh AK, Varga J,. The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J Cell Physiol 2007; 213: 663-671. (Pubitemid 350058260)
61. Ghosh AK, Yuan W, Mori Y, et al,. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGFβ involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000; 19: 3546-3555. (Pubitemid 30487452)
62. Bhattacharyya S, Ghosh AK, Pannu J, et al,. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factorβ. Arthritis Rheum 2005; 52: 1248-1258. (Pubitemid 40530133)
63. Collins S, Lutz MA, Zarek PE, et al,. Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur J Immunol 2008; 38: 528-536.
64. Zhu B, Symonds AL, Martin JE, et al,. Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupus-like autoimmune disease. J Exp Med 2008; 205: 2295-2307.
65. Sela U, Dayan M, Hershkoviz R, et al,. A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3. J Immunol 2008; 180: 1584-1591.
66. Le N, Nagarajan R, Wang JY, et al,. Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci USA 2005; 102: 2596-2601. (Pubitemid 40279422)
67. Fang F, Ooka K, Bhattacharyya S, et al,. The early growth response gene Egr2 (alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses. Am J Pathol 2011; 178: 2077-2090.
68. Busquets J, Del Galdo F, Kissin EY, et al,. Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis employing confocal laser scanning microscopy: an objective outcome measure for clinical trials? Rheumatology (Oxford) 2010; 49: 1069-1075.
69. Scharffetter K, Lankat-Buttgereit B, Krieg T,. Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization. Eur J Clin Invest 1988; 18: 9-17.
70. Svaren J, Sevetson BR, Golda T, et al,. Novel mutants of NAB corepressors enhance activation by Egr transactivators. EMBO J 1998; 17: 6010-6019. (Pubitemid 28474794)
71. Swirnoff AH, Apel ED, Svaren J, et al,. Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain. Mol Cell Biol 1998; 18: 512-524. (Pubitemid 28021062)
72. Le N, Nagarajan R, Wang JY, et al,. Nab proteins are essential for peripheral nervous system myelination. Nat Neurosci 2005; 8: 932-940.
73. Laslo P, Spooner CJ, Warmflash A, et al,. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006; 126: 755-766. (Pubitemid 44233633)
74. Buitrago M, Lorenz K, Maass AH, et al,. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med 2005; 11: 837-844. (Pubitemid 41161115)
75. Abdulkadir SA, Carbone JM, Naughton CK, et al,. Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Hum Pathol 2001; 32: 935-939. (Pubitemid 32911315)
76. Bhattacharyya S, Wei J, Melichian DS, et al,. The transcriptional cofactor nab2 is induced by TGFβ and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma. PLoS One 2009; 4: e7620.
77. Matute-Bello G, Wurfel MM, Lee JS, et al,. Essential role of MMP-12 in Fas-induced lung fibrosis. Am J Respir Cell Mol Biol 2007; 37: 210-221. (Pubitemid 47255004)
78. Fichtner-Feigl S, Young CA, Kitani A, et al,. IL-13 signaling via IL-13R α2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 2008; 135: 2003-2013, e2001-2007.
79. Derdak Z, Villegas KA, Wands JR,. Early growth response-1 transcription factor promotes hepatic fibrosis and steatosis in long-term ethanol-fed Long-Evans rats. Liver Int 2012; 32: 761-770.
80. Nakamura H, Isaka Y, Tsujie M, et al,. Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial α-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Gene Ther 2002; 9: 495-502. (Pubitemid 34449769)
81. Chen ZH, Kim HP, Sciurba FC, et al,. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One 2008; 3: e3316.
82. Zhang W, Yan SD, Zhu A, et al,. Expression of Egr-1 in late stage emphysema. Am J Pathol 2000; 157: 1311-1320.
83. Pritchard MT, Nagy LE,. Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-deficient mice. Am J Pathol 2010; 176: 2743-2752.
84. Pritchard MT, Cohen JI, Roychowdhury S, et al,. Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. J Hepatol 2010; 53: 655-662.
85. Kim ND, Moon JO, Slitt AL, et al,. Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci 2006; 90: 586-595.
86. Ponticos M, Abraham D, Alexakis C, et al,. Col1a2 enhancer regulates collagen activity during development and in adult tissue repair. Matrix Biol 2004; 22: 619-628. (Pubitemid 38520091)
87. Reynolds PR, Cosio MG, Hoidal JR,. Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells. Am J Respir Cell Mol Biol 2006; 35: 314-319. (Pubitemid 44353399)
88. Ning W, Dong Y, Sun J, et al,. Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts. Am J Respir Cell Mol Biol 2007; 36: 480-490. (Pubitemid 46623007)
89. Bot PT, Hoefer IE, Sluijter JP, et al,. Increased expression of the transforming growth factor-β signaling pathway, endoglin, and early growth response-1 in stable plaques. Stroke 2009; 40: 439-447.
90. Boon K, Bailey NW, Yang J, et al,. Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One 2009; 4: e5134.
91. Grigoryev DN, Mathai SC, Fisher MR, et al,. Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. Transl Res 2008; 151: 197-207.
92. Dickinson MG, Bartelds B, Molema G, et al,. Egr-1 expression during neointimal development in flow-associated pulmonary hypertension. Am J Pathol 2011; 179: 2199-2209.
93. Milano A, Pendergrass SA, Sargent JL, et al,. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 2008; 3: e2696.
94. Sargent JL, Milano A, Bhattacharyya S, et al,. A TGFβ-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity. J Invest Dermatol 2010; 130: 694-705.
95. Farivar AS, MacKinnon-Patterson B, Barnes AD, et al,. The effect of anti-inflammatory properties of mycophenolate mofetil on the development of lung reperfusion injury. J Heart Lung Transpl 2005; 24: 2235-2242. (Pubitemid 41814751)
96. Bea F, Blessing E, Shelley MI, et al,. Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. Atherosclerosis 2003; 167: 187-194. (Pubitemid 36773519)
97. Farivar AS, Mackinnon-Patterson BC, Barnes AD, et al,. Cyclosporine modulates the response to hypoxia-reoxygenation in pulmonary artery endothelial cells. Ann Thorac Surg 2005; 79: 1010-1016. (Pubitemid 40288766)
98. Okada M, Yan SF, Pinsky DJ,. Peroxisome proliferator-activated receptor-γ (PPARγ) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J 2002; 16: 1861-1868. (Pubitemid 35462604)
99. Wan H, Yuan Y, Liu J, et al,. Pioglitazone, a PPARγ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor. J Pathol 2013; [in press].
100. Leask A,. Egr-ly awaiting a personalized medicine' approach to treat scleroderma. J Cell Commun Signal 2012; 6: 111-113.